Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 24573196)

1.

A possible origin of emerged HIV-1 after interrupting anti-retroviral therapy.

Matsumura J, Shimizu M, Omi K, Nagata N, Shinya E, Oka S, Takahashi H.

Biomed Res. 2014;35(1):1-8.

2.

HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?

Jiao Y, Wang P, Zhang H, Zhang T, Zhang Y, Zhu H, Wu H.

Immunol Invest. 2011;40(6):597-613. doi: 10.3109/08820139.2011.569673. Epub 2011 Apr 25.

PMID:
21513481
3.

Seminal reservoirs during an HIV type 1 eradication trial.

Nunnari G, Leto D, Sullivan J, Xu Y, Mehlman KE, Kulkosky J, Pomerantz RJ.

AIDS Res Hum Retroviruses. 2005 Sep;21(9):768-75.

PMID:
16218800
4.

Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo.

Kulkosky J, Sullivan J, Xu Y, Malin-Markham A, Otero M, Calarota S, Zielinski J, Culnan DM, Pomerantz RJ.

Virology. 2003 Sep 30;314(2):617-29.

5.

Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.

Price DA, Scullard G, Oxenius A, Braganza R, Beddows SA, Kazmi S, Clarke JR, Johnson GE, Weber JN, Phillips RE.

J Virol. 2003 May;77(10):6041-9.

6.

HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences.

Michael NL, Chang G, Ehrenberg PK, Vahey MT, Redfield RR.

J Acquir Immune Defic Syndr. 1993 Oct;6(10):1073-85.

PMID:
8105071
7.

Identification of human immunodeficiency virus type 1 subtypes B and F B/F recombinant and dual infection with these subtypes in Argentina.

Fernández-Medina D, Jansson M, Rabinovich RD, Libonatti O, Wigzell H.

Scand J Infect Dis. 1999;31(3):235-42.

PMID:
10482050
8.

Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption.

Silva WP, Santos DE, Leal E, Brunstein A, Sucupira MC, Sabino EC, Diaz RS.

Virology. 2006 Oct 10;354(1):35-47. Epub 2006 Jul 25.

9.

Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.

Bruce C, Clegg C, Featherstone A, Smith J, Biryahawaho B, Downing R, Oram J.

AIDS Res Hum Retroviruses. 1994 Nov;10(11):1543-50.

PMID:
7888209
10.

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.

Imaz A, Olmo M, Peñaranda M, Gutiérrez F, Romeu J, Larrousse M, Domingo P, Oteo JA, Niubó J, Curto J, Vilallonga C, Masiá M, López-Aldeguer J, Iribarren JA, Podzamczer D; STOPAR Study Team.

Antivir Ther. 2012;17(3):577-83. doi: 10.3851/IMP2025. Epub 2011 Dec 19. Erratum in: Antivir Ther. 2012;17(3):597.

PMID:
22301439
11.

Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy.

Brumme ZL, Dong WW, Yip B, Wynhoven B, Hoffman NG, Swanstrom R, Jensen MA, Mullins JI, Hogg RS, Montaner JS, Harrigan PR.

AIDS. 2004 Mar 5;18(4):F1-9.

PMID:
15090786
12.
13.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.

J Med Virol. 2004 Jul;73(3):350-61.

PMID:
15170628
14.

Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.

Shaheen F, Sison AV, McIntosh L, Mukhtar M, Pomerantz RJ.

J Hum Virol. 1999 May-Jun;2(3):154-66.

PMID:
10413367
15.

Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function.

Vecchi M, Burighel N, Bellanova D, Menzo S, De Rossi A, Clementi M, Bagnarelli P.

New Microbiol. 2004 Apr;27(2 Suppl 1):99-104.

PMID:
15646071
17.
18.

HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.

Re MC, Vitone F, Biagetti C, Schiavone P, Alessandrini F, Bon I, de Crignis E, Gibellini D.

Clin Microbiol Infect. 2010 Jun;16(6):640-6. doi: 10.1111/j.1469-0691.2009.02826.x. Epub 2009 Sep 2.

19.

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Günthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK.

J Virol. 2005 Feb;79(3):1772-88.

20.

Cell type-specific heterogeneity of the HIV-1 V3 loop in infected individuals: selection of virus in macrophages and plasma.

Yamashita A, Yamamoto N, Matsuda J, Koyanagi Y.

Virology. 1994 Oct;204(1):170-9.

PMID:
7916512
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk